On 2025-05-13, Kyverna Therapeutics, Inc. (KYTX) announced earnings per share of $-1.03 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.21.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-1.00 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-1.21 | $-1.03 |
| 2025-03-27 | 2024-12-31 | $-0.87 | $-0.88 |
| 2024-11-13 | 2024-09-30 | $-0.77 | $-0.80 |
| 2024-08-12 | 2024-06-30 | $-0.70 | $-0.67 |
| 2024-05-14 | 2024-03-31 | $-0.88 | $-1.12 |